Zobrazeno 1 - 5
of 5
pro vyhledávání: '"N M Croft"'
Autor:
R Hansen, S Meade, F Torrente, J Kammermeier, N M Croft, L de Ridder, D C Wilson, R Klomberg, D Turner, J Martín-de-Carpi, J Bronsky, E Benchimol, J Amil-Dias, D R Mack, G Walker, M Powar, N Burgess, C H van Ommen, P M Irving, M Samaan
Publikováno v:
Journal of Crohn's and Colitis. 16:i526-i527
Background Thromboprophylaxis is routinely used in adults with active inflammatory bowel disease (IBD), particularly inpatients, but not in children. Current ECCO/ESPGHAN guidelines support thromboprophylaxis only in children with acute severe coliti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::959309c188adf25cf03dafd089c4c032
https://doi.org/10.1093/ecco-jcc/jjab232.716
https://doi.org/10.1093/ecco-jcc/jjab232.716
Autor:
M Heredia, L M M Costes, I Tindemans, M A Aardoom, R C W Klomberg, P Kemos, M E Joosse, D H van Haaften, B Tuk, F Ruemmele, N M Croft, J C Escher, L de Ridder, J N Samsom
Publikováno v:
Journal of Crohn's and Colitis. 16:i161-i161
Background Crohn’s disease (CD) and ulcerative colitis (UC) are characterized by intestinal infiltration of pathogenic effector CD4+ T cells. The defects driving loss of T-cell regulation vary between patients and remain undefined. Previously, we h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5423d28e6f9be4acf3d77c1b74fe97d7
https://doi.org/10.1093/ecco-jcc/jjab232.174
https://doi.org/10.1093/ecco-jcc/jjab232.174
Autor:
D C, Wilson, A G, Thomas, N M, Croft, E, Newby, A K, Akobeng, A, Sawczenko, J M E, Fell, M S, Murphy, R M, Beattie, B K, Sandhu, S G, Mitton, D, Casson, M, Elawad, R, Heuschkel, H, Jenkins, T, Johnson, S, Macdonald, S H, Murch
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 50:S14-S34
Objective: to systematically review the evidence base for the medical (pharmaceutical and nutritional) treatment of paediatric inflammatory bowel disease. Methods: key clinical questions were formulated regarding different treatment modalities used i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffcab4f116d11c5feef0fb0643a84a56
https://doi.org/10.1097/mpg.0b013e3181c92caa
https://doi.org/10.1097/mpg.0b013e3181c92caa
Publikováno v:
Archives of Disease in Childhood. 91:426-432
Twenty five per cent of inflammatory bowel disease presents in childhood. Growth and nutrition are key issues in the management with the aim of treatment being to induce and then maintain disease remission with minimal side effects. Only 25% of Crohn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13698319afc43d8da67047034f1a4a63
https://doi.org/10.1136/adc.2005.080481
https://doi.org/10.1136/adc.2005.080481
Publikováno v:
Postgraduate medical journal. 72
Fibrosing colonopathy is a recently described complication of cystic fibrosis, of unknown aetiology but possibly related to treatment with high-dose pancreatic enzyme supplements. We have used a whole gut perfusion technique to study subclinical gut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b27f6599c238a85d982207ae27635a06
https://pubmed.ncbi.nlm.nih.gov/8869180
https://pubmed.ncbi.nlm.nih.gov/8869180